New long-term treatment data confirms consistent benefit and safety profile of Pradaxa ® beyond 6 years

New long-term treatment data confirms consistent benefit and safety profile of Pradaxa ® beyond 6 years

Source: Boehringer Ingelheim Corporate News - November 27, 2017 Category: Research Source Type: news